John Ayuk Selected Research

Parathyroid Hormone (Parathormone)

10/2010

New perspectives in the management of primary hyperparathyroidism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Ayuk Research Topics

Disease

11	Acromegaly 01/2021 - 09/2002
6	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 03/2005
4	Neoplasms (Cancer) 01/2021 - 01/2009
4	Hypopituitarism (Sheehan's Syndrome) 01/2018 - 11/2004
3	Prolactinoma (Prolactinomas) 01/2018 - 11/2017
2	Craniopharyngioma (Craniopharyngiomas) 01/2022 - 04/2016
2	Adenoma (Adenomas) 01/2018 - 01/2017
2	Pituitary Diseases (Disease, Anterior Pituitary) 06/2010 - 01/2009
1	Bipolar Disorder (Manic Depressive Psychosis) 05/2022
1	Coma (Comas) 05/2022
1	Seizures (Absence Seizure) 05/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Hypertension (High Blood Pressure) 12/2019
1	Hypotension (Low Blood Pressure) 12/2019
1	Breast Neoplasms (Breast Cancer) 03/2019
1	Melanoma (Melanoma, Malignant) 03/2019
1	Neoplasm Metastasis (Metastasis) 03/2019
1	Adrenal incidentaloma 03/2019
1	Injection Site Reaction 08/2018
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2018
1	Hypertensive Crisis 01/2018
1	Hyperprolactinemia 01/2018
1	Diabetes Insipidus 01/2018
1	Hypothyroidism 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Infarction (Infarctions) 04/2016
1	Flushing 02/2016
1	Short Bowel Syndrome 04/2014
1	Hypocalcemia 04/2014
1	Renal Insufficiency (Renal Failure) 03/2014
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2012
1	Stroke (Strokes) 03/2012
1	Acidosis 12/2011
1	Primary Hyperparathyroidism 10/2010
1	Pituitary ACTH Hypersecretion 06/2010
1	Central Nervous System Neoplasms 01/2009
1	Vascular System Injuries 01/2009
1	Pituitary Apoplexy 12/2004
1	Glucose Intolerance 09/2002

Drug/Important Bio-Agent (IBA)

7	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 04/2009
5	Growth Hormone (Somatotropin)IBA 01/2021 - 04/2009
5	Hormones (Hormone)IBA 03/2019 - 06/2010
4	ProlactinIBA 01/2018 - 11/2017
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 09/2002
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2018 - 11/2004
3	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2018 - 06/2010
3	MagnesiumIBA 04/2014 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 09/2002
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018 - 06/2010
2	GonadotropinsIBA 11/2016 - 06/2010
2	Octreotide (Sandostatin)FDA LinkGeneric 02/2016 - 03/2004
2	pegvisomant FDA LinkGeneric 04/2009 - 11/2004
1	LithiumIBA 05/2022
1	Psychotropic Drugs (Psychoactive Drugs)IBA 05/2022
1	Protons (Proton)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	cyclo(Arg-Pro) (CI 4)IBA 12/2019
1	NormetanephrineIBA 12/2019
1	Antisense OligonucleotidesIBA 08/2018
1	ATL 227446IBA 08/2018
1	Phentolamine (Z-Max)FDA LinkGeneric 01/2018
1	Insulin-Like PeptidesIBA 01/2018
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2018
1	Parathyroid Hormone (Parathormone)IBA 10/2010
1	Pharmaceutical PreparationsIBA 04/2009
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 11/2004

Therapy/Procedure

12	Radiotherapy 01/2022 - 03/2004
7	Therapeutics 12/2019 - 09/2002
1	Adrenalectomy 03/2019
1	Adjuvant Radiotherapy 01/2018
1	Duration of Therapy 01/2018
1	Conservative Treatment 12/2004